Screen detected breast cancer in an Asian population: Pathological findings of the Singapore breast screening project

Breast

Volumn 8, Issue 3, 1999, Pages 120-125

  Tan, P H ^a   Chiang, G S C ^a   Ng, E H ^a   Low, S C ^a   Ng, F C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER SCREENING; CHINESE; CLINICAL FEATURE; COMEDO; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; SINGAPORE; TUMOR VOLUME;

EID: 0032840694     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.1999.0038     Document Type: Article

References (43)

1. Chia, K, S, Lee, H, P, Seow, A, Shanmugaratnam, K, Trends in cancer incidence in Singapore 1968-1992, Singapore Cancer Registry Report No. 4, 1996.
2. Seow A, Duffy S W, McGee M A, Lee J, Lee H P. Breast cancer in Singapore: trends in incidence 1968-1992. Int J Epidemiol. 25:1996;40-45.
3. Singapore Demographic Bulletin, Registry of Births and Deaths, National Registration Department, August 1997.
4. Fieg S A. Decreased breast cancer mortality through mammographic screening: results of clinical trials. Radiology. 167:1988;659-665.
5. Tabar L, Fagerberg C J G, Gad A. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the breast cancer screening working group of the Swedish National Board of Health and Welfare. Lancet. 1:1985;829-832.
6. Fletcher S W, Black W, Harris R, Rimer B K, Shapiro S. Special Article. Report of the international workshop on screening for breast cancer. J Natl Cancer Inst. 85:1993;1644-1655.
7. Shapiro S. Evidence on screening for breast cancer from a randomised trial. Cancer. 39:1977;2772-2782.
8. Ng E H, Ng F C, Tan P H. Results of intermediate measures from a population-based, randomised trial of mammographic screening prevalence and detection of breast carcinoma among Asian women. The Singapore breast screening project. Cancer. 82:1998;1521-1528.
9. Elston C W, Ellis I O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 19:1991;403-410.
10. Elston C W. Grading of invasive carcinoma of the breast. Page D L, Anderson T J. Diagnostic histopathology of the breast. 1987;300-311 Edinburgh, Churchill Livingstone.
11. Beahrs O H, Henson D E, Hutter R V P, Kennedy B J. Manual for staging of cancer, 4th ed. 1992;149-154 J B Lippincott, Philadelphia.
12. Tan P H, Sng I T Y. Male breast cancer: a retrospective study with immunohistochemical analysis of hormone receptor expression. Pathology. 29:1997;2-6.
13. Rosen P P. Intraductal carcinoma. Rosen's breast pathology. 1997;Lippincott-Raven, Philadelphia. p. 260-265.
14. Pathology reporting in breast screening. 1995;NHSBSP Publications, Sheffield.
15. Connolly J L, Schnitt S J. Evaluation of breast biopsy specimens in patients considered for treatment by conservative surgery and radiation therapy for early breast cancer. Pathol Annu. 23:1988;1-23.
16. Coleman M P, Esteve J, Damiecki P, Arslan A, Renard H. Trends in cancer incidence and mortality. 1993;IARC Scientific Publications No.121, Lyon. p. 411-432.
17. Ng E H, Gao F, Ji C Y, Ho G H, Soo K C. Risk factors for breast carcinoma in Singaporean Chinese women. The role of central obesity. Cancer. 80:1997;725-731.
18. Algaratnam T T, Wong J. Limitations of mammography in Chinese females. Clin Radiol. 36:1985;175-177.
19. Schnitt S J, Silen W, Sadowsky N L, Connolly J L, Harris J R. Current concepts. Ductal carcinoma in situ (intraductal carcinoma) of the breast. N Engl J Med. 318:1988;898-903.
20. Pinder S E, Ellis I O. Atypical ductal hyperplasia, ductal carcinoma in situ and in situ atypical apocrine proliferations of the breast. Curr Diagn Pathol. 3:1996;235-242.
21. Lagios M D. Duct carcinoma in situ: pathology and treatment. Surg Clin North Am. 70:1990;853-871.
22. Elston C W, Ellis I O. Pathology and breast screening. Histopathology. 16:1990;109-118.
23. Cady B, Stone M D, Schuler J G, Thakur R, Wanner M A, Lavin P T. The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg. 131:1996;301-308.
24. Jatoi I, Baum M. Mammographically detected ductal carcinoma in situ: are we overdiagnosing breast cancer. Surgery. 118:1995;118-120.
25. Holland R, Peterse J L, Millis R R. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol. 11:1994;167-180.
26. King J M. A practical approach to breast ductal carcinoma in situ and tumours with an extensive intraductal component. Pathology. 26:1994;90-93.
27. Schwartz G F, Patchefsky A S, Finklestein S D. Nonpalpable in situ ductal carcinoma of the breast. Arch Surg. 124:1989;29-32.
28. Bellamy C O C, McDonald C, Salter D M, Chetty U, Anderson T J. Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol. 24:1993;16-23.
29. Schwartz G F, Finkel G C, Garcia J C, Patchefsky A S. Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone. Cancer. 70:1992;2468-2474.
30. Page D L, Dupont W D, Rogers L W, Landenberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer. 49:1982;751-758.
31. Weidner N. Breast diseases. Weidner N. The difficult diagnosis in surgical pathology. 1996;644-649 W. B. Saunders Company, Philadelphia.
32. Anderson T J. Breast cancer screening: principles and practicalities for histopathologists. Anthony P P, MacSween R N M. Recent advances in histopathology. 1989;43-61 Churchill Livingstone, Edinburgh.
33. Connolly J L, Schnitt S J. Miscellaneous features of carcinoma - extent of invasive disease. Page D L, Anderson T J. Diagnostic histopathology of the breast. 1987;278 Churchill Livingstone, Edinburgh.
34. Tavassoli F A. Infiltrating carcinomas, common and familiar special types - microinvasive carcinoma. Tavassoli F A. Pathology of the breast. 1992;298-300 Appleton & Lange, Norwalk.
35. Anderson T J, Lamb J, Donnan P. Comparative pathology of breast cancer in a randomised trial of screening. Br J Cancer. 64:1991;108-113.
36. Pinder S E, Ellis I O, Elston C W. Prognostic factors in primary breast carcinoma. J Clin Pathol. 48:1995;981-983.
37. Ellis I O, Galea M, Broughton N, Locker A, Blamey R W, Elston C W. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology. 20:1992;479-489.
38. Bennington J L, Lagios M D, Margolin F R. Impact of mammographic screening on the size and the relative frequency of invasion in breast cancers seen in a community hospital from 1975-1988. Bennington J L, Lagios M D. The mammographically directed biopsy. 1992;11-21 Hanley & Belfus Inc, Philadelphia.
39. Tabar L, Fagerberg C J G, South M C, Day N E, Duffy S W. The Swedish two-county trial of mammographic screening for breast cancer: recent results on mortality and tumour characteristics. Miller A B, Chamberlain J, Day N E. Cancer screening. 1991;23-36 Cambridge University Press, Cambridge.
40. McCann J, Wait S, Seradour B, Day N. A comparison of the performance and impact of breast cancer screening in East Anglia, U.K. and Bouches Du Rhône, France. Eur J Cancer. 33:1997;429-435.
41. Holland P A, Walls J, Boggis C R M, Knox F, Baildam A D, Bundred N J. A comparison of axillary node status between cancers detected at the prevalence and first incidence breast screening rounds. Br J Cancer. 74:1996;1643-1646.
42. Leitner S P, Swern A S, Weinberger D, Duncan L J, Hutter R V P. Predictors of recurrence for patients with small (one centimetre or less) localised breast cancer (T1a,bN0M0). Cancer. 76:1995;2266-2274.
43. Day N E, Williams D R R, Khaw K T. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer. 59:1989;954-958.